Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03844789 · ClinicalTrials.gov registry record · NA
A Study of t:Slim X2 With Control-IQ Technology
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 101
- Enrollment target
NCT03844789 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 101 participants.
The verdict
NCT03844789, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
Study Summary
The purpose of this study is to learn whether an investigational automated insulin delivery system ("study system") for children with type 1 diabetes can safely improve blood glucose (sometimes called blood sugar) control. The system uses continuous glucose monitoring (CGM), an insulin pump, and a software algorithm to automatically give insulin and control blood glucose. This is called a "closed-loop control" system.
Interventions
- DEVICE Control Group
- DEVICE t:slim X2 with Control-IQ Technology & Dexcom G6 CGM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2019-06-06 |
| Est. Completion | 2020-03-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03844789
The ClinicalTrials.gov registry entry for NCT03844789 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control Group is the first listed.
NCT03844789 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03844789 about?
NCT03844789 is a clinical study titled "A Study of t:Slim X2 With Control-IQ Technology". The purpose of this study is to learn whether an investigational automated insulin delivery system ("study system") for children with type 1 diabetes can safely improve blood glucose (sometimes called blood sugar) control. The system uses continuous glucose monitoring (CGM), an insulin pump, and a s...
What is the current status of trial NCT03844789?
This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2019-06-06. Estimated completion is 2020-03-20.
What interventions are being tested in trial NCT03844789?
The interventions under investigation include: Control Group (DEVICE), t:slim X2 with Control-IQ Technology & Dexcom G6 CGM (DEVICE).
Who is sponsoring clinical trial NCT03844789?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.